Ketamine dependency requires an individual clinical assessment, particularly because patterns of use, physical health, psykisk hälsa and withdrawal experiences can vary considerably between individuals.
InHarmoni’s published treatment information states that the centre treats drug addiction and substance-use disorders, alongside co-occurring mental health conditions. However, ketamine is not specifically named in the centre’s current published list of substances, so anyone seeking treatment specifically for ketamine dependency should discuss their circumstances with the clinical team during the admission process.
Why does the assessment matter?
A person using ketamine may also experience anxiety, depression, trauma, compulsive behaviour or other substance use.
Those factors can change the most appropriate treatment plan.
At InHarmoni, the initial assessment considers the individual rather than placing every client through an identical programme.
The residential programme can include medical assessment and supervision, psychological evaluation, individual therapy, CBT, ACT, trauma-informed treatment, relapse prevention and family support.
What happens if other substances are involved?
Polydrug use is important to disclose during assessment.
The clinical team needs to understand all substances being used, frequency of use, medications, physical health and mental health history before determining whether residential treatment is appropriate and what level of medical support may be required.
If you are considering treatment for ketamine dependency at InHarmoni, the best first step is a confidential clinical conversation rather than assuming that every programme is suitable for every pattern of use.
Lämna ett svar